This programme, running until 2023, aims to eliminate trachoma in at least nine African countries, make significant progress in several others, and build on ground-breaking research into the link between the antibiotic used to treat trachoma and a reduction in childhood mortality. Sightsavers and our partners will also work alongside endemic countries to help strengthen healthcare systems so progress continues in the long-term.
Which countries are involved?
Accelerate aims to eliminate trachoma as a public health risk in Benin, Botswana, Burkina Faso, Cameroon, Guinea-Bissau, Guinea, Namibia, Senegal, and Tanzania. It also aims to make progress towards trachoma elimination in Cote d’Ivoire, Ethiopia, Kenya, Nigeria and Zimbabwe.
Thanks to the work of endemic countries and the support of individuals, families and organisations such as USAID, The END Fund, Conrad Hilton Foundation and The Queen Elizabeth Diamond Jubilee Trust, since 2002 the number of people at risk of trachoma has dropped by 91%.
It is now within our grasp to make history by ridding the world of this painful disease. But more funding and support is needed to finish the work we’ve started.
Ophthalmic nurse Givemore travels to remote communities in Zimbabwe to examine people for signs of blinding trachoma. He wants to make sure everyone is treated so their sight can be saved.Read his story